ScholarIQanswers from OpenAlex
Novartis Pharmaceuticals Corporation
FunderResearch funding and supported work
Novartis Pharmaceuticals Corporation is a funder indexed in ScholarIQ from OpenAlex.
What is known about Novartis Pharmaceuticals Corporation?
ScholarIQrecord summary
American multinational biotechnology firm (1981-2006)
How many works does Novartis Pharmaceuticals Corporation have?
ScholarIQindexed works
Novartis Pharmaceuticals Corporation has 7,314 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Novartis Pharmaceuticals Corporation?
ScholarIQopenalex
The OpenAlex for Novartis Pharmaceuticals Corporation is on the source record.
What is the ROR of Novartis Pharmaceuticals Corporation?
ScholarIQror
The ROR for Novartis Pharmaceuticals Corporation is on the source record.
What are the most-cited papers on Novartis Pharmaceuticals Corporation?
ScholarIQmost cited works
Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
Eric J. Velazquez, David A. Morrow, Adam D. DeVore, Carol I. Duffy, Andrew P. Ambrosy, Kevin McCague, Ricardo Rocha, Eugene Braunwald
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
Muthiah Vaduganathan, Robert J. Mentz, Brian Claggett, Zi Michael Miao, Ian J. Kulac, Jonathan H. Ward, Adrian F. Hernandez, David A. Morrow, Randall C. Starling, Eric J. Velazquez, Kristin Williamson, Akshay S. Desai, Shelley Zieroth, Martin Lefkowitz, John J.V. McMurray, Eugene Braunwald, Scott D. Solomon
Atopic Dermatitis in US Adults: From Population to Health Care Utilization
Jonathan I. Silverberg, Joel M. Gelfand, David J. Margolis, Mark Boguniewicz, Luz Fonacier, Mitchell H. Grayson, Peck Y. Ong, Zelma C. Chiesa Fuxench, Eric L. Simpson
Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome
Kandai Nozu, Yutaka Takaoka, Hirofumi Kai, Minoru Takasato, Kensuke Yabuuchi, Tomohiko Yamamura, Tomoko Horinouchi, Nana Sakakibara, Takeshi Ninchoji, China Nagano, Kazumoto Iijima
Cardiovascular-Kidney-Metabolic Overlap in Heart Failure with Preserved Ejection Fraction: Cardiac Structure and Function, Clinical Outcomes, and Response to Sacubitril/Valsartan in PARAGON-HF
Mats Christian Højbjerg Lassen, John W. Ostrominski, Brian Claggett, Milton Packer, Michael R. Zile, Akshay S. Desai, Amil M. Shah, Maja Čikeš, Béla Merkely, Mauro Gori, Xiaowen Wang, Sheila M. Hegde, Marc A. Pfeffer, Martin Lefkowitz, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan